S
MDGL icon

SignatureFD’s Madrigal Pharmaceuticals MDGL Stock Holding History

SignatureFD’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72K Buy
134
+7
+6% +$3.59K ﹤0.01% 1650
2026
Q1 		$66.5K Buy
127
+12
+10% +$5.73K ﹤0.01% 1555
2025
Q4 		$67K Hold
115
– – ﹤0.01% 1497
2025
Q3 		$52.7K Sell
115
-11
-9% -$4.1K ﹤0.01% 1616
2025
Q2 		$38.1K Sell
126
-10
-7% -$2.98K ﹤0.01% 1734
2025
Q1 		$45K Buy
136
+3
+2% +$986 ﹤0.01% 1629
2024
Q4 		$41K Sell
133
-6
-4% -$1.69K ﹤0.01% 1689
2024
Q3 		$29.5K Sell
139
-6
-4% -$1.53K ﹤0.01% 1856
2024
Q2 		$40.6K Buy
145
+39
+37% +$9.28K ﹤0.01% 1616
2024
Q1 		$28.3K Buy
106
+4
+4% +$942 ﹤0.01% 1824
2023
Q4 		$23.6K Buy
102
+10
+11% +$1.75K ﹤0.01% 1842
2023
Q3 		$13.4K Buy
92
+53
+136% +$9.98K ﹤0.01% 2050
2023
Q2 		$9.01K Hold
39
– – ﹤0.01% 2280
2023
Q1 		$9.45K Hold
39
– – ﹤0.01% 2238
2022
Q4 		$11.3K Buy
+39
New +$3.81K ﹤0.01% 2089
2022
Q1 		– Sell
-54
Closed -$5K – 3253
2021
Q4 		$5K Buy
54
+50
+1,250% +$4.11K ﹤0.01% 2400
2021
Q3 		$0 Sell
4
-33
-89% -$2.85K ﹤0.01% 3146
2021
Q2 		$4K Sell
37
-8
-18% -$947 ﹤0.01% 2361
2021
Q1 		$5K Buy
+45
New +$5.25K ﹤0.01% 2144
2020
Q3 		– Sell
-7
Closed -$1K – 2696
2020
Q2 		$1K Buy
+7
New +$688 ﹤0.01% 2337

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SignatureFD's MDGL Position: Q2 2026 in Review

SignatureFD increased its Madrigal Pharmaceuticals (MDGL) stake by 5.5% in Q2 2026, buying an estimated $3.59K and bringing the position to 134 shares worth $72K. The position accounts for ﹤0.01% of the portfolio, ranked #1650.

SignatureFD first reported a position in MDGL in Q2 2020 and has held it in 20 quarters since. 415 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • SignatureFD held 134 shares of Madrigal Pharmaceuticals worth $72K as of Q2 2026.
  • SignatureFD bought 7 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $3.59K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1650 holding.
  • SignatureFD first reported a position in Madrigal Pharmaceuticals in Q2 2020 and has held it in 20 quarters since.
  • 415 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.